Literature DB >> 7706354

Recurrence of infection after revision of infected hip arthroplasties.

P Went1, M Krismer, B Frischhut.   

Abstract

We performed revision surgery for infected arthroplasty in 98 hips (96 patients). In 28 hips infection persisted. Of the remaining 70 hips, 61 (87%) were reviewed after a mean interval of 5.9 years (1 to 17). Infection occurred in 10% of these after three years and in 26% after ten years. The infection rate after initially successful revision for septic arthroplasty is higher than after revision for aseptic loosening and the risk of developing infection continues for many years.

Entities:  

Mesh:

Year:  1995        PMID: 7706354

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  5 in total

Review 1.  Recognition and management of bacterial arthritis.

Authors:  M A Cimmino
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

2.  [Risk factors for failed cleansing following periprosthetic delayed hip prosthesis infection].

Authors:  U Spiegl; R Pätzold; J Friederichs; M Militz; V Bühren
Journal:  Orthopade       Date:  2012-06       Impact factor: 1.087

3.  Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study.

Authors:  Mélanie Gilson; Laure Gossec; Xavier Mariette; Dalenda Gherissi; Marie-Hélène Guyot; Jean-Marie Berthelot; Daniel Wendling; Christian Michelet; Pierre Dellamonica; Florence Tubach; Maxime Dougados; Dominique Salmon
Journal:  Arthritis Res Ther       Date:  2010-07-16       Impact factor: 5.156

4.  TREATMENT OF INFECTION AFTER TOTAL KNEE ARTHROPLASTY.

Authors:  Ricardo de Paula Leite Cury; Eduardo Hitoshi Tsuge Cinagawa; Osmar Pedro Arbix Camargo; Emerson Kiyoshi Honda; Giselle Burlamaqui Klautau; Mauro José Costa Salles
Journal:  Acta Ortop Bras       Date:  2015 Sep-Oct       Impact factor: 0.513

5.  Antimicrobial performance of mesoporous titania thin films: role of pore size, hydrophobicity, and antibiotic release.

Authors:  Saba Atefyekta; Batur Ercan; Johan Karlsson; Erik Taylor; Stanley Chung; Thomas J Webster; Martin Andersson
Journal:  Int J Nanomedicine       Date:  2016-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.